Biogen Inc. (BIIB)

About Biogen Inc. (BIIB)

Company Description:


Biogen Inc., a pioneering biopharmaceutical company, is significantly involved in the discovery, development, and delivery of innovative therapies for treating neurological and neurodegenerative diseases. It operates primarily in the Drug Manufacturers – General industry within the Healthcare sector.

Biogen was founded in 1978 by several eminent biologists, including Nobel Prize winners Walter Gilbert and Phillip Sharp. The company is headquartered in Cambridge, Massachusetts, United States, and has been a leader in neuroscience research and treatment advancements.


Main Product(s):


Biogen's portfolio mainly focuses on treatments for multiple sclerosis and neurodegenerative diseases, including therapies like Tecfidera, Avonex, and Tysabri for multiple sclerosis, and Spinraza for spinal muscular atrophy. The company also has a growing pipeline of potential therapies for Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS).


Short History of Biogen Inc.:


  • 1978 – Biogen was founded by a group of scientists including Nobel laureates.
  • 1983 – Biogen went public.
  • 2003 – Merged with Idec Pharmaceuticals, focusing more on neurology.
  • 2015 – Announced restructuring to focus more on neurodegenerative diseases.
  • 2020 – Received FDA approval for its Alzheimer's disease drug, Aduhelm.

Key Executives:

NameTitlePayExercisedYear Born
Mr. Christopher A. ViehbacherPresident, CEO & Director487.94kN/A1961
Mr. Michael R. McDonnell CPAExecutive VP & CFO2.12MN/A1964
Ms. Nicole MurphyHead of Pharmaceutical Operations & Technology1.46MN/AN/A
Ms. Susan H. Alexander Esq.Executive VP & Chief Legal Officer2.2MN/A1957
Dr. Ginger GregoryExecutive VP & Chief Human Resources Officer1.59MN/A1968
Ms. Robin C. KramerSenior VP & Chief Accounting OfficerN/AN/A1966
Mr. Charles E. TrianoSenior VP & Head of Investor RelationsN/AN/AN/A
Ms. Natacha GassenbachChief Communication Officer & Head of Corporate AffairsN/AN/AN/A
Mr. Adam Keeney Ph.D.Executive VP & Head of Corporate DevelopmentN/AN/AN/A
Ms. Alisha A. AlaimoPresident & Head of North AmericaN/AN/AN/A

Trade smart with Robert Lindner

Charts and financial information provided by TradingView, a popular charting & trading platform.

Check out even more advanced features or grab charts for your website.